{"disease":{"id":"leukocyte-chemotactic-factor-2-amyloidosis","name":"leukocyte chemotactic factor 2 amyloidosis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03774784","title":"A Study of the Natural History of Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Disease","phase":"","overall_status":"TERMINATED","enrollment_count":26,"lead_sponsor_name":"Alnylam Pharmaceuticals","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}